⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Cipla USA, Inc.: Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX

DrugsSource: FDA (drug) · Date: 2026-01-28

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Cipla

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Cipla USA, Inc.
Product
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
Reason / hazard
Failed PH Specifications
Classification
Class III
Status
Ongoing
Distribution / sold at
Nationwide in the USA
Recall initiated
2025-12-22
Code info
Batch XHBG; Exp. 08/31/2027
Product quantity
92,376 tubes
Voluntary mandated
Voluntary: Firm initiated
City
Warren
State
NJ
Country
United States
Event id
98193
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.